3. Equity (Details Narrative) - USD ($) |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
Dec. 31, 2017 |
|
Share-based compensation expense | $ 242,209 | $ 44,016 | |
Options [Member] | |||
Share-based compensation expense | $ 242,209 | $ 44,016 | |
Options granted | 175,000 | ||
Vesting term | 8 years 11 months 4 days | ||
Option expiration period | 10 years | ||
Option exercise price | $ 2.21 | ||
Aggregate intrinsic value options exercisable | $ 543,181 | ||
Options [Member] | Employee [Member] | |||
Vesting term | 4 years | ||
Options [Member] | Two Consultants [Member] | |||
Vesting term | 1 year | ||
Warrants [Member] | |||
Share-based compensation expense | $ 76,262 | ||
Aggregate intrinsic value of warrants exercisable | $ 3,471,865 | ||
2017 Stock Plan [Member] | |||
Shares authorized under plan | 2,000,000 |
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|